Continuous Delivery of Levodopa May Decrease Motor Complications of OFF Time

 

A small open-label study, published in the journal Movement Disorders, compared the efficacy and pharmacokinetics of continuously administered oral levodopa/carbidopa (sips administered at 5- to 10-minute intervals) for treatment of Parkinson's disease (PD) vs the current standard treatment taken once or twice per day for treatment. In this study, 18 patients with PD took the continuous dose for 8 hours or their usual dose alternating between the 2 treatments every other day. Patients had 43% less mean OFF time when they took the continuous treatment than when they took the standard treatment (P <.001).

During each 8-hour study period, blood samples were drawn between 4 and 8 hours when patients were in a relatively steady state. Blood samples drawn when patients were using the continuous dosing had less variability in plasma levodopa concentration compared with when they took their standard dose. The fluctuation index was 0.99 ± 0.09 for continuous treatment vs 1.38 ± 0.12 for standard dosing and the coefficient of variation was 0.35 ± 0.03 vs. 0.49 ± 0.04, respectively (<.001 for both measures). 

 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC